atorvastatin - lifescience intellipedia...atorvastatin domestic market research report analysis 1...
TRANSCRIPT
ATORVASTATIN
Domestic Market Research Report Analysis
1
proprietary & confidential
CHAPTER 1- PRODUCT BASIC INTRODUCTION
CHAPTER 2- PRODUCT-GLOBAL FORMS, VARIANTS, GRADES & APPLICATION INSIGHTS
CHAPTER 3-PRODUCT-MARKET SIZE TREND
CHAPTER 4- BUYERS ANALYSI
Table of content
2proprietary & confidential
CHAPTER 1- PRODUCT BASIC INTRODUCTION
3proprietary & confidential
BASIC INTRODUCTION
Atorvastatin134523-00-5
Antihyper-lipidemic
Oral
Synonym
(βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)-carbonyl]-1H-pyrrole-1-heptanoic acid
(βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-pyrrole-1-heptanoic acid
C33H35FN2O5
4proprietary & confidential
ATORVASTATIN- HISTORY AND BACKGROUND
• Originated by Warner Lambert
• Bruce D Roth who is in park Davis(Division of Pfizer) took 3 weeks to get atorvastatin from raw material.
• Donald Back guided clinical trials for atorvastatin
• Formulation Development was done by Pfizer
• Atorvastatin ( Lipitor) Launched in 1997 (USA)
• In 2009 lipitorbrought in over13 billion US dollar for Pfizer
5
proprietary & confidential
CHAPTER 2- PRODUCT-GLOBAL FORMS, VARIANTS, GRADES &
APPLICATION INSIGHTS
6
proprietary & confidential
Variants
AtorvastatinAtorvastatin
CalciumAtorvastatin
Diprotected
Atorvastatin Trihydrate
Atorvastatin LactoneCrystalline Amorphous
Forms
Atorvastatin
CHAPTER 2- PRODUCT-GLOBAL FORMS, VARIANTS, GRADES &
APPLICATION INSIGHTS
7
proprietary & confidential
Stroke
Angina
Myocardial infarction
Revascularization procedures
Diabetes (Type 2 diabetes)
Reduce the risk of myocardial
infarction
Reduce the risk of stroke
Hyperlipidemia
Cardiovascular Disease
Homozygous familial
hypercholesterolemia
Heterozygous familial
hypercholesterolemia (Diet)
PRODUCT- APPLICATION INSIGHTS
8
proprietary & confidential
CHAPTER 3-PRODUCT-MARKET SIZE TREND
9proprietary & confidential
India Total Production Volume (Size) 244 MT
Export 111 MT
Domestic Consumption 111 MT
Inventory (10% of Export + Domestic) 22 MT
ATORVASTATIN: INDIA MARKET SIZE JAN-14 TO DEC-14
10
proprietary & confidential
DOMESTIC CONSUMPTION: BIFURCATION
Domestic Consumption 111MT
Buyers involved in formulation only 54 MT
API Manufacturer having their own
formulation brands
46 MT
Inventory (10%of total) 11MT
11
proprietary & confidential
CHAPTER 4- BUYER ANALYSIS
12
proprietary & confidential
13
Total Buyers of Domestic Market 120
Largest Buyer Sharon Biomedicine Ltd
Sharon Biomedicine Buying Quantity
(MT)
6
Product
Name
Buyer
Name
Buying
Quantity
/
Year
Unit Contact
Person
Designation Email
ID
Phone
No.
Atorvastati
n
Sharon
Bio
Medici
ne Ltd.
6000 Kg Savita
Gowda
Owner purchas
e@sharo
nbio.co
m
2267944
000
Atorvastatin: Domestic Deliverable Format
BUYER ANALYSIS
proprietary & confidential
Contact for any country Domestic Buyer Market Research Report :-
Life science Intellipedia
Suite no- 209, C- 104, Sector- 65 Noida, UP- 201301
Contact No- 0120 6900 550-565
Email address- [email protected]
14
proprietary & confidential